TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML
Resource Type
Article
Authors
Mohamed, Aminetou Mint ; Balsat, Marie ; Koering, Catherine ; Maucort-Boulch, Delphine ; Boissel, Nicolas ; Payen-Gay, Lea ; Cheok, Meyling ; Mortada, Hussein ; Auboeuf, Didier ; Pinatel, Christiane ; El-Hamri, Mohamed ; Tigaud, Isabelle ; Hayette, Sandrine ; Dumontet, Charles ; Cros, Emeline ; Flandrin-Gresta, Pascale ; Nibourel, Olivier ; Preudhomme, Claude ; Thomas, Xavier ; Nicolini, Franck-Emmanuel ; Solly, Françoise ; Guyotat, Denis ; Campos, Lydia ; Michallet, Mauricette ; Ceraulo, Antony ; Mortreux, Franck ; Wattel, Eric
Source
In Leukemia Research May 2017 56:21-28
Subject
Language
ISSN
0145-2126